Starting on:
May 26, 2022
Ending on:
May 26, 2022
Moderator(s):
Venue:
KEMRI-KWTRP/Virtual
Max Credits:
3 Points
Provider:
KEMRI-WELLCOME TRUST RESEARCH PROGRAMME
Claim Points
May 26, 2022
Ending on:
May 26, 2022
Moderator(s):
KEMRI-KWTRP/Virtual
Max Credits:
3 Points
Provider:
KEMRI-WELLCOME TRUST RESEARCH PROGRAMME
Claim Points
Vaccines for Shigella â?? vaccine developer perspectiveâ?.
Starting on:
May 26, 2022 4:00 PM
May 26, 2022 4:00 PM
Ending on:
May 26, 2022 5:00 PM
May 26, 2022 5:00 PM
Venue:
KEMRI-KWTRP/Virtual
KEMRI-KWTRP/Virtual
Description
Weekly scientific seminar
Objectives
Vaccines for Shigella â?? vaccine developer perspectiveâ?.
Presenters
-
Dr.
Francesca Micoli
Project Leader of the Shigella project and Director of the Innovation Academy at GSK Vaccine Institute for Global Health (GVGH) focused on innovative technologies for vaccine development.
GSK Vaccine Institute -
Dr.
Cristina Alaimo
Clinical Director at LimmaTech Biologics AG spearheading the clinical development of Shigella vaccines. She has extensive experience working in industry.
LimmaTech Biologics -
Dr.
Christiane Gerke
Head of Vaccine Programs at the Institute Pasteur, Paris, France,
Institute Pasteur